Tag Archives: advanced oncotherapy major shareholder list

Tag Archives: advanced oncotherapy major shareholder list

Advanced Oncotherapy (AVO) – Major Shareholder increases stake

Advanced Oncotherapy (AVO) – Updated major shareholder list to include Bracknor Investment Group

Advanced Oncotherapy (AVO) – Major Shareholder increases stake

Advanced Oncotherapy (AVO) – Updated major shareholder list to include Bracknor Investment Group

Recent Posts

Home » Posts tagged 'advanced oncotherapy major shareholder list'

21st March 2017 / Leave a comment

NOTIFICATION OF MAJOR INTEREST IN SHARES

download movie War for the Planet of the Apes 2017

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ

Advanced Oncotherapy plc

2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights		X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	AB Segulah
4. Full name of shareholder(s) (if different from 3.): ^iv	HSBC Global Custody Nominee (UK)
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	20 March 2017
6. Date on which issuer notified:	20 March 2017
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	5%

8. Notified details:
A: Voting rights attached to shares ^{viii, ix}
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction		Resulting situation after the triggering transaction
	Number of Shares	Number of Voting Rights	Number of shares	Number of voting rights		% of voting rights ^x
			Direct	Direct ^xi	Indirect^xii	Direct	Indirect
Ordinary Shares GBP 0.25 GB00BD6SX109	3,505,451	3,505,451	3,680,451	3,680,451		5.06%

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument	Expiration date ^xiii	Exercise/ Conversion Period ^xiv	Number of voting rights that may be acquired if the instrument is exercised/ converted.	% of voting rights

Total (A+B+C)
Number of voting rights	Percentage of voting rights
3,680,451	5.06%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: ^xxi

The 3,680,451 shares are held by HSBC Global Custody Nominee (UK) under direct control of AB Segulah.

Proxy Voting:
10. Name of the proxy holder:	N/A
11. Number of voting rights proxy holder will cease to hold:	N/A
12. Date on which proxy holder will cease to hold voting rights:	N/A

13. Additional information:	N/A
14. Contact name:	David Navas, AVO plc
15. Contact telephone number:	020 3873 2051

15th March 2017 / Leave a comment

Advanced Oncotherapy (AVO) – Major Shareholders

Shares in issue: 72,467,783

Major Shareholders Information
Shareholder	Number of Shares	% of Total In Issue
Brahma AG	10,850,491	15.0%
Mr Michael Stephen Bradfield	7,080,740	9.8%
MK Trust Co., LTD	4,850,000	6.7%
Michael Sinclair & Family	4,628,229	6.4%
Banca Profilo SPA	3,750,000	5.2%
Hargreaves Lansdown Asset Mgt	3,592,410	5.0%
AB Segulah	3,369,451	4.6%
Aviva Investors	3,212,036	4.4%
Dr P N Plowman	2,636,799	3.6%
Pi-Capital LLC	2,000,000	2.8%
Barclays Wealth and Investment Management (UK)	1,671,916	2.3%
Credit Suisse (Italy) SPA	1,575,000	2.2%
Michael Peter Stephen Horgan	1,502,563	2.1%
Halifax Share Dealing	1,485,378	2.0%
TD Direct Investing	1,243,975	1.7%
Alliance Trust Savings	1,032,307	1.4%
Walker Crips Wealth Mgt.Ltd	1,026,969	1.4%
Fundsdirect	963,146	1.3%
Mijesi AB	950,143	1.3%
Selftrade – Talos Securities	949,047	1.3%
Bracknor Investment Group⁽¹⁾	829,410	1.1%
Dr Enrico C Vanni	823,946	1.1%
Bestinvest	805,591	1.1%
Interactive Investor Sharedealing	733,541	1.0%
Other holdings, below 1%	11,734,105	16.2%
Total In Issue	72,467,783	100%

Director’s Information
Shareholder	Number of Shares	% of Total In Issue
Holdings by Directors or Holdings Under Their Control
Michael Bradfield	7,080,740	9.8%
Dr Michael Sinclair & Family	4,628,229	6.4%
Dr Enrico C Vanni	823,946	1.1%
Nicolas Serandour	93,800	0.1%
Mr Sanjeev Pandya	58,616	0.1%
Prof Steve Myers	50,569	0.1%
Prof Chris Nutting	14,816	0.0%
Hans von Celsing	0	0.0%
	12,750,716	17.6%

(1) Advanced Oncotherapy plc has been informed by Bracknor Investment Group that as of March 14th 2017 they have increased their stake in the company by buying shares on the open market.

This information was last updated on 30 January 2017.

Share price data provided by vwd group & financial data provided by Morningstar.

Link here to view on the Advanced Oncotherapy website.

I would like to receive Brand Communications updates and news...

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise
price

Expiration
date ^xvii

Exercise/
Conversion
period ^xviii

Number of voting
rights instrument
refers to

% of voting rights^{xix, xx}